FY ended March 2022

• Japan: Sales decreased 0.7%. Nihon Kohden concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on consumables and services business as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. Sales of Patient Monitors increased favorably and demand for certain products which had slumped in FY2020 recovered. The resumption of business negotiations related to IT system solutions also contributed to sales. Sales of locally purchased products decreased significantly as the Company focused on selling in-house products. Sales in the private hospital and clinic markets increased and sales in the university hospital market remained flat. Sales in the public hospital market decreased and sales of AEDs in the PAD market also decreased.
• International: Sales increased 10.2%. Sales of all product categories increased as the Company succeeded in strengthening its business structure in the U.S. and emerging countries. Demand for certain products which had slumped in FY2020 recovered in all regions. Sales of consumables and services also increased favorably. Sales in the Americas and Asia & Other achieved double-digit growth, while sales in Europe decreased due to a reactionary decline from FY2020 when demand increased.

• Americas: Sales increased 10.4%. Sales in the U.S. increased favorably. Sales in Latin America decreased due to a reactionary decline in Columbia where sales doubled in FY2020. 
• Europe: Sales decreased 12.9%. Demand for certain products recovered, but not enough to cover the reactionary decline compared to the strong growth in FY2020.  
• Asia & Other: Sales increased 25.7%. Sales in India, Thailand, Malaysia, and Egypt doubled, and sales in China and Vietnam also increased favorably.